Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Toru Yamano"'
Publikováno v:
Journal of Pharmaceutical Health Services Research. 13:333-340
Objectives This study aimed to identify drug-related problems (DRPs) using data regarding the communication of pharmacists with prescribers over the phone at a community pharmacy. Furthermore, we elucidated the frequency of the sources of information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d698e585da50ab3ada86213c26d4735d
https://doi.org/10.1093/jphsr/rmac035
https://doi.org/10.1093/jphsr/rmac035
Publikováno v:
Lecture Notes in Civil Engineering ISBN: 9789811973307
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91ce6778895f945eda296a2a4a58b1d8
https://doi.org/10.1007/978-981-19-7331-4_35
https://doi.org/10.1007/978-981-19-7331-4_35
Publikováno v:
Japanese Journal of JSCE. 79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d62e50973504671ee1df2f12254a11c
https://doi.org/10.2208/jscejj.22-22009
https://doi.org/10.2208/jscejj.22-22009
Autor:
Eiji Kimura, Naohiro Taya, Katsuaki Oda, Mitsuyoshi Nishitani, Masayuki Yamashita, Toru Yamano, Yuji Ishichi, Jun Terauchi, Tetsuji Kawamoto
Publikováno v:
Tetrahedron: Asymmetry. 26:935-942
The novel triple reuptake inhibitor ( S )-4-(1-(3,4-dichlorophenyl)-2-methoxyethyl)piperidine monohydrochloride 1 possesses a unique 2-phenyl-2-(piperidin-4-yl)ethanol moiety with a stereogenic center at the benzyl position. To synthesize 1 as the (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef77e209e3d56ba4a642aaff2c4d99e4
https://doi.org/10.1016/j.tetasy.2015.06.021
https://doi.org/10.1016/j.tetasy.2015.06.021
Autor:
Kenji Kusaba, Toru Yamano, Akihito Hagihara, Erina Kaneko, Takashi Seo, Manabu Yoshikawa, Masahisa Kato, Rika Eguchi
Publikováno v:
YAKUGAKU ZASSHI. 135:501-506
Much of the damage to health caused by drugs could be prevented by appropriate care. A well-defined duty of care and further information are required for healthcare professionals. Although there are many litigation cases to use as references, neither
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d493d0a412a6202789e4cd66f42560e9
https://doi.org/10.1248/yakushi.14-00204
https://doi.org/10.1248/yakushi.14-00204
Publikováno v:
Bulletin of the Chemical Society of Japan. 87:539-543
A preparation via Rh-catalyzed asymmetric hydrogenation has been developed for (2,3-dihydrobenzofuran-3-yl)acetic acid derivatives, a key intermediate in the synthesis of the active pharmaceutical ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bfdc2c668c82f180443ff3fe84116fd
https://doi.org/10.1246/bcsj.20130324
https://doi.org/10.1246/bcsj.20130324
Autor:
Hua Zou, Douglas R. Dougan, Kohji Fukatsu, Keiko Kakegawa, Masaaki Funata, Mitsuo Yamamoto, Clifford D. Mol, Katsuhiko Miwa, Akiyoshi Tani, Hiroyuki Watanabe, Makoto Kamata, Bi-Ching Sang, Jyun-ichi Sakamoto, Gyorgy Snell, Satoshi Endo, Tohru Yamashita, Toru Yamano
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:6314-6318
The co-crystal structure of the human acetyl-coenzyme A 2 (ACC2) carboxyl transferase domain and the reported compound CP-640186 (1b) suggested that two carbonyl groups are essential for potent ACC2 inhibition. By focusing on enhancing the interactio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3474640bac449e5b7c5fcfd06f9d9302
https://doi.org/10.1016/j.bmcl.2011.08.117
https://doi.org/10.1016/j.bmcl.2011.08.117
Autor:
Trevor Laird, Jaan A. Pesti, Ahmed F. Abdel-Magid, Daniel Levin, Tony Y. Zhang, Sean P. Lapekas, Thomas Archibald, Stephen M. Stefanick, Ryo Sugiyama, Toru Yamano, Joerg Deerberg, Stefan Abele, Gunther Schmidt, Jacques-Alexis Funel, Mischa Schwaninger, Sven Wagner, Noel A. Hamill, Mark E. Howells, James H. Simpson, Atul S. Kotnis, Rajendra P. Deshpande, David J. Kacsur, Jason Hamm, Gus Kodersha, William Merkl, Daniel Domina, Steve Y. Wang, Nicholas A. Straessler, Louis F. Cannizzo, Michael W. Lesley, Oliver R. Thiel, John R. Huckins, Derek B. Brown, Eric A. Bercot, John T. Colyer, Bobby Riahi, Rob R. Milburn, Steve M. Shaw, Joe Tomaskevitch, David J. Ager, Ayman Allian, Bryan Li, Steven Guinness, L. Mleczko, Dongbo Zhao, Sripathy Venkatraman, Scott Tweedie, Mark McLaws, David Lathbury
Autor:
Osamu Uchikawa, Toru Yamano, Kiyoharu Matsumoto, Mari Adachi, Kohji Fukatsu, Shigenori Ohkawa, Masayuki Yamashita, Mitsutaka Tanaka, Mitsuru Kawada
Publikováno v:
Tetrahedron: Asymmetry. 17:184-190
Asymmetric synthesis of a novel non-benzodiazepine hypnotic drug Ramelteon (TAK-375) was accomplished via asymmetric hydrogenation. Development of the substrate design revealed that a novel class of substrate, allylic acylamine 4a, was hydrogenated w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33a53d76d45e175c552445df77c641fd
https://doi.org/10.1016/j.tetasy.2005.11.005
https://doi.org/10.1016/j.tetasy.2005.11.005
Publikováno v:
Tetrahedron: Asymmetry. 14:3525-3531
A practical method for the preparation of ( R )-(+)-6-(1,4-dimethoxy-3-methyl-2-naphthyl)-6-(4-hydroxyphenyl)hexanoic acid ( R )- 2 , a key intermediate for a therapeutic drug for neurodegenerative diseases, has been developed. rac -Methyl 6-(1,4-dim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37d28549ce988f605ed3e379be04b32c
https://doi.org/10.1016/s0957-4166(03)00580-9
https://doi.org/10.1016/s0957-4166(03)00580-9